HYPERCAPNIC HYPERVENTILATION SPEEDS EMERGENCE from INHALED ANESTHESIA by Nishant a Gopalakrishnan a Dissertation Submitted to T
Total Page:16
File Type:pdf, Size:1020Kb
HYPERCAPNIC HYPERVENTILATION SPEEDS EMERGENCE FROM INHALED ANESTHESIA By Nishant A Gopalakrishnan A dissertation submitted to the faculty of The University of Utah in partial fulfillment of the requirements of Doctor of Philosophy Department of Bioengineering The University of Utah December 2006 Copyright © Nishant A Gopalakrishnan 2006 All Rights Reserved THE UNIVERSITY OF UTAH GRADUATE SCHOOL SUPERVISORY COMMITTEE APPROVAL of a dissertation submitted by This dissertation has been read by each member of the following supervisory committee and by majority vote has been found to be satisfactory. __________________ _________________________________________ Chair: __________________ _________________________________________ __________________ _________________________________________ __________________ _________________________________________ __________________ _________________________________________ THE UNIVERSITY OF UTAH GRADUATE SCHOOL FINAL READING APPROVAL To the Graduate Council of the University of Utah: I have read the dissertation of in its final form and have found that (1) its format, citations, and bibliographic style are consistent and acceptable; (2) its illustrative materials including figures, tables, and charts are in place; and (3) the final manuscript is satisfactory to the supervisory committee and is ready for submission to The Graduate School. ________________________ ______________________________________ Date Chair: Supervisory Committee Approved for the Major Department _____________________________________ Chair/Dean Approved for the Graduate Council _____________________________________ David S. Chapman Dean of The Graduate School ABSTRACT Anesthetic clearance from the lungs and the circle breathing system can be maximized using hyperventilation and high fresh gas flow. However, the concomitant clearance of CO2 also lowers arterial partial pressure of CO2 thereby decreasing cerebral blood flow and hence the clearance of anesthetic from the brain. Emergence time from inhaled anesthesia can be significantly reduced by maintaining hypercapnia (feedback controlled infusion of CO2 or rebreathing) during hyperventilation. We anesthetized seven pigs with 2 MACPIG (minimum alveolar concentration) of isoflurane and four each with 2 MACPIG of sevoflurane or 1 MACPIG of desflurane. After two hours of anesthesia, the animals were hyperventilated and the time to movement of multiple limbs was measured under hypocapnic (EtCO2=22 mmHg) and hypercapnic (EtCO2=55 mmHg) conditions. Emergence time from isoflurane and sevoflurane anesthesia was shortened by an average of 65% with rebreathing or with the CO2 controller (p<0.05). The emergence times obtained from rebreathing were not statistically different from those obtained from precisely tuned feedback controller. We evaluated the differences in emergence time in fifty two surgical patients undergoing 1 MAC of isoflurane, sevoflurane or desflurane anesthesia under mild hypocapnia (EtCO2=29 mmHg) and mild hypercapnia (EtCO2=55 mmHg). The minute ventilation in half the patients was doubled during emergence and hypercapnia was maintained by insertion of additional airway dead space to keep the EtCO2 close to 55 mmHg during hyperventilation. A charcoal canister adsorbed volatile anesthetic agent from the rebreathed dead space. Fresh gas flow was raised to 10 L/min during emergence in all the patients. The time between turning off the vaporizer and the time when the patients opened their eyes in response to command was faster when hypercapnic hyperventilation was maintained using the rebreathing adsorber (p<0.05). The time to tracheal extubation was shortened by 57%. We used a multi compartmental mathematical model to estimate cerebral awakening concentration of anesthetic agent (when patients responded to a command to open eyes) and emergence times from anesthesia. The normalized cerebral awakening concentration to age adjusted MAC for desflurane, sevoflurane and isoflurane were 0.162 ± 0.044, 0.280 ± 0.058 and 0.356 ± 0.105 respectively. The root mean square error of the performance error (calculated as a percent of the predicted value) was between 10% and 24%. The model estimated that there will be at least a 56% reduction in emergence time with hypercapnic hyperventilation. The emergence time after isoflurane, sevoflurane and desflurane anesthesia was shortened significantly by using hypercapnic hyperventilation. The rebreathing device described in the study should be considered following a surgical procedure where a high concentration of the anesthetic agent is maintained right up to the end of the procedure or when surgery ends abruptly without warning. v TABLE OF CONTENTS ABSTRACT. iv LIST OF TABLES . viii LIST OF FIGURES . ix ACNOWLEDGEMENTS. xi 1. INTRODUCTION . 1 1.1. Inhaled Anesthetic Agents. 1 1.2. Anesthesia Delivery System. 2 1.3. MAC and MACawake. 2 1.4. Pharmacology of Inhaled Anesthetics. 4 1.5. Recovery from Anesthesia. 5 1.6. Importance of a Rapid Recovery. 9 1.7. References. 13 2. ANIMAL STUDIES . 15 2.1. Abstract . 15 2.2. Introduction. 16 2.3. Methods. 17 2.4. Results. 27 2.5. Discussion. 38 2.6. Conclusions. 42 2.7. References. 42 3. CLINICAL EVALUATION OF REBREATHING DEVICE . 45 3.1. Abstract . 45 3.2. Introduction. 46 3.3. Methods. 48 3.4. Results. 52 3.5. Discussion. 53 3.6. Conclusions. 64 3.7. References. 65 4. MODEL TO PREDICT EMERGENCE FROM INHALED ANESTHESIA . 68 4.1. Abstract . 68 4.2. Introduction. 69 4.3. Methods. 72 4.4. Results. 86 4.5. Discussion. 87 4.6. Conclusions. 100 4.7. References. 101 5. SUMMARY AND CONCLUSIONS . 104 5.1. Project Overview . 104 5.2. Conclusions . 108 5.3. Limitations of the Study. 109 5.4. Future Work. 110 5.5. References. 111 APPENDIX: EQUATIONS USED IN THE MATHEMATICAL MODEL. 113 vii LIST OF TABLES Table Page 1.1. Tissue/blood partition coefficients. 6 1.2. Average cost of 1 MAC hour of anesthesia. 12 2.1. Average time to spontaneous breathing, EtCO2 during emergence, pre-emergence minute ventilation and emergence minute ventilation. 28 3.1. Patient demographics. 54 3.2. Duration of surgery and total dose of opioids. 55 3.3. EtCO2 at extubation, pre-emergence and emergence BIS and minute ventilation. 56 3.4. Time to open eyes, mouth and extubation. 57 4.1. Volume and blood flow for each compartment. 75 4.2. Partition coefficients used in the model. 76 4.3. Performance measures of the model during each trial. 91 4.4. Estimated emergence times after 0.5, 2 and 8 hours of anesthesia . 92 4.5. Estimated total inhaled and exhaled agent after 0.5,2 and 8 hours of anesthesia. 93 LIST OF FIGURES Figure Page 1.1. Circle breathing circuit. 3 2.1. Block diagram of feedback controller. 19 2.2. Rebreathing device with rebreathing hose, activated charcoal and one-way valves. 21 2.3. Simulated EtCO2 for a various rebreathing hose volumes . 23 2.4. Normalized BIS during emergence from isoflurane and desflurane . 29 2.5. Average time to movement of multiple limbs after isoflurane, sevoflurane and desflurane anesthesia.. 30 2.6. Average time to normalized BIS to rise to 0.95 after isoflurane, sevoflurane and desflurane anesthesia . 31 2.7. Average time to movement of multiple limbs after 1 MAC of desflurane anesthesia. 33 2.8. Typical controller tuning curves for the proportional constant. 34 2.9. Typical controller tuning curves for the integral constant. 35 2.10. Response of the controller for a step change in ventilation and set point. 36 2.11. Inspired agent concentration for the rebreathing device with and without valves. 37 3.1. Rebreathing device . 50 3.2. Normalized BIS during emergence from isoflurane, sevoflurane and desflurane anesthesia. 58 3.3. Average time to tracheal extubation after isoflurane, sevoflurane and desflurane anesthesia . 59 3.4. Average time to normalized BIS to rise to 0.95 after isoflurane, sevoflurane and desflurane anesthesia. 60 4.1. Schematic of the compartments in the model. 73 4.2. Predicted and measured emergence times from 1 MAC of desflurane . 88 4.3. Predicted and measured emergence times from 1 MAC of sevoflurane. 89 4.4. Predicted and measured emergence times from 1 MAC of isoflurane. 90 4.5. Estimated emergence times from 1 MAC of desflurane for different combinations of EtCO2 and minute ventilation. 94 4.6. Estimated emergence times from 1 MAC of sevoflurane for different combinations of EtCO2 and minute ventilation. 95 4.7. Estimated emergence times from 1 MAC of isoflurane for different combinations of EtCO2 and minute ventilation. 96 x ACKNOWLEDGMENTS First and foremost, I would like to thank Dr Westenskow for his generous support and for providing me with an opportunity to work with him on this project. I will always look back on my five years in the Anesthesia Bioengineering Laboratory with great fondness. I appreciate the time and guidance provided by the members of my supervisory committee: Dwayne Westenskow, Joseph Orr, Douglas Christensen, Kenneth Horch and Derek Sakata. I am also indebted to Robert G. Loeb at the University of Arizona, who reviewed this dissertation and provided many useful comments. I would like to thank Dr Sakata for his guidance and assistance with the clinical studies and Scott Mc James for his assistance with the animal studies. I would also like to thank Joseph Orr for his able guidance throughout the project. I am grateful to Anecare Laboratories for their support and interest in this project, to the Society of Technology in Anesthesia and the Anesthesiology Department at the University of Utah for the financial support they have provided.